Chris Proffitt - Cylene Pharmaceut | 人才画像

基本信息

浏览量：6

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 31 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Design and Discovery of a Potent and Selective Inhibitor of Integrin Αvβ1

Mark Sabat,Daniel W. Carney,Gloria Hernandez-Torres,Tony S. Gibson,Deepika Balakrishna,Hua Zou, Rui Xu, Chien-Hung Chen,Ron de Jong,Douglas R. Dougan, Ling Qin,Simone V. Bigi-Botterill, Alison Chambers,Joanne Miura, Lucas K. Johnson,Jacques Ermolieff, Deidre Johns,Jangir Selimkhanov,Lily Kwok,Kevin Dement,Chris Proffitt,Phong Vu,Erick A. Lindsey, Tony Ivetac,Andy Jennings, Haixia Wang, Padma Manam, Cipriano Santos, Cody Fullenwider,Rohan Manohar,Andrew C. Flick

JOURNAL OF MEDICINAL CHEMISTRYno. 12 (2024): 10306-10320

引用0浏览0WOS引用

Data from Anticancer Activity of CX-3543: A Direct Inhibitor of rRNA Biogenesis

Denis Drygin,Adam Siddiqui-Jain,Sean O'Brien,Michael Schwaebe,Amy Lin,Josh Bliesath,Caroline B. Ho,Chris Proffitt,Katy Trent,Jeffrey P. Whitten,John K. C. Lim,Daniel Von Hoff,Kenna Anderes,William G. Rice

crossref（2023）

引用0浏览0引用

Supplementary Figure 1 from CK2 Inhibitor CX-4945 Suppresses DNA Repair Response Triggered by DNA-Targeted Anticancer Drugs and Augments Efficacy: Mechanistic Rationale for Drug Combination Therapy

Adam Siddiqui-Jain,Joshua Bliesath,Diwata Macalino,Mayuko Omori,Nanni Huser,Nicole Streiner,Caroline B. Ho,Kenna Anderes,Chris Proffitt,Sean E. O'Brien,John K. C. Lim,Daniel D. Von Hoff,David M. Ryckman,William G. Rice,Denis Drygin

openalex（2023）

引用0浏览0引用

Supplementary Methods and Materials from Anticancer Activity of CX-3543: A Direct Inhibitor of rRNA Biogenesis

crossref（2023）

引用0浏览0引用

Supplementary Methods, Figure Legends 1-3 from CK2 Inhibitor CX-4945 Suppresses DNA Repair Response Triggered by DNA-Targeted Anticancer Drugs and Augments Efficacy: Mechanistic Rationale for Drug Combination Therapy

Adam Siddiqui-Jain,Joshua Bliesath,Diwata Macalino,Mayuko Omori,Nanni Huser,Nicole Streiner,Caroline B. Ho,Kenna Anderes,Chris Proffitt, Sean O’Brien, Jeehee Lim,Daniel D. Von Hoff,David M. Ryckman,William G. Rice,Denis Drygin

openalex

引用0浏览0引用

Supplementary Figure 2 from CK2 Inhibitor CX-4945 Suppresses DNA Repair Response Triggered by DNA-Targeted Anticancer Drugs and Augments Efficacy: Mechanistic Rationale for Drug Combination Therapy

openalex

引用0浏览0引用

Supplementary Methods from CX-4945, an Orally Bioavailable Selective Inhibitor of Protein Kinase CK2, Inhibits Prosurvival and Angiogenic Signaling and Exhibits Antitumor Efficacy

Adam Siddiqui-Jain,Denis Drygin,Nicole Streiner,Peter Chua,Fabrice Pierre,Sean E. O'Brien,Josh Bliesath,Mayuko Omori,Nanni Huser,Caroline Ho,Chris Proffitt,Michael K. Schwaebe,David M. Ryckman,William G. Rice,Kenna Anderes

crossref（2023）

引用0浏览0引用

Biochemical and Cellular Profile of NIK Inhibitors with Long Residence Times

Petro Halkowycz,Charles E. Grimshaw,Walter Keung, Paul Tanis,Chris Proffitt, Kim Peacock,Ron de Jong,Mark Sabat, Urmi Banerjee,Jacques Ermolieff

SLAS discovery（2021）

引用1浏览0WOS引用

Combined inhibition of EGFR and CK2 augments the attenuation of PI3K-Akt-mTOR signaling and the killing of cancer cells

Joshua Bliesath,Nanni Huser,Mayuko Omori,Daniel Bunag,Chris Proffitt,Nicole Streiner,Caroline Ho,Adam Siddiqui-Jain,Sean E O'Brien,John K C Lim,David M Ryckman,Kenna Anderes,William G Rice,Denis Drygin

Cancer Letters（2012）

引用71浏览0WOS引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn